Clinical Trials
3 trialsNCT00601913 2018-07-05
Erlotinib and Surgery in Treating Patients With Head and Neck Cancer That Can Be Removed by Surgery
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT02277457 2016-06-24
Personalized Adaptive Radiation Therapy With Individualized Systemic Targeted Therapy (PARTIST) for Locally Advanced, Non-small Cell Lung Cancer With Genomic Driver Mutations
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Withdrawn
NCT00140556 2013-01-18
Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer
Duke University
Phase EARLY_PHASE1 Completed